335
Views
21
CrossRef citations to date
0
Altmetric
Report

The efficacy of fractional carbon dioxide (CO2) laser combined with terbinafine hydrochloride 1% cream for the treatment of onychomycosis

, , , , , , , & show all
Pages 353-359 | Received 14 Dec 2016, Accepted 13 May 2017, Published online: 10 Jul 2017

References

  • Ghannoum MA, Hajjeh RA, Scher R, Konnikov N, Gupta AK, Summerbell R, et al. A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. J Am Acad Dermatol. 2000;43(4):641–648. doi:10.1067/mjd.2000.107754 PMID:11004620
  • Gupta AK, Paquet M, Simpson FC. Therapies for the treatment of onychomycosis. Clin Dermatol. 2013;31(5):544–554. doi:10.1016/j.clindermatol.2013.06.011 PMID:24079583
  • Ledon JA, Savas J, Franca K, Chacon A, Nouri K. Laser and light therapy for onychomycosis: a systematic review. Lasers Med Sci. 2014;29(2):823–829. doi:10.1007/s10103-012-1232-y PMID:23179307
  • Yang Y, Liu H, Yang RY, Huang XX, Jing DY, Wang L, et al. Efficacy of a superpulse-mode fractional carbon dioxide laser for the treatment of onychomycosis: a clinical observational study. Chinese J Dermatol. 2015;48(8):526–530.
  • Lim EH, Kim HR, Park YO, Lee Y, Seo YJ, Kim CD, et al. Toenail onychomycosis treated with a fractional carbon-dioxide laser and topical antifungal cream. J Am Acad Dermatol. 2014;70(5):918–923. doi:10.1016/j.jaad.2014.01.893 PMID:24655819
  • Bhatta AK, Keyal U, Huang X, Zhao JJ. Fractional carbon-dioxide (CO2) laser-assisted topical therapy for the treatment of onychomycosis. J Am Acad Dermatol. 2016;74(5):916–923. doi:10.1016/j.jaad.2015.12.002 PMID:26874820
  • Borovoy M, Tracy M. Noninvasive CO2 laser fenestration improves treatment of onychomycosis. Clin Laser Mon. 1992;10(8):123–124. PMID:10147745
  • Yaemsiri S, Hou N, Slining MM, He K. Growth rate of human fingernails and toenails in healthy American young adults. J Eur Acad Dermatol Venereol. 2010;24(4):420–423. doi:10.1111/j.1468-3083.2009.03426.x PMID:19744178
  • Ryder NS. Terbinafine: mode of action and properties of the squalene epoxidase inhibition. Br J Dermatol. 1992;126(Suppl. 390:2–7. PMID:1543672
  • Choudhary S, Bisati S, Singh A, Koley S. Efficacy and safety of terbinafine hydrochloride 1% cream vs. sertaconazole nitrate 2% cream in Tinea corporis and Tinea cruris: a comparative therapeutic trial. Indian J Dermatol. 2013;58(6):457–460. doi:10.4103/0019-5154.119958 PMID:24249898
  • Xu Y, Miao X, Zhou B, Luo D. Combined oral terbinafine and long-pulsed 1,064-nm Nd: YAG laser treatment is more effective for onychomycosis than either treatment alone. Dermatol Surg. 2014;40(11):1201–1207. doi:10.1097/DSS.0000000000000157. PMID:25322165
  • Thomas J, Jacobson GA, Narkowicz CK, Peterson GM, Burnet H, Sharpe C. Toenail onychomycosis: an important global disease burden. J Clin Pharm Ther. 2010;35(5):497–519. doi:10.1111/j.1365-2710.2009.01107.x PMID:20831675
  • Jo Siu WJ, Tatsumi Y, Senda H, Pillai R, Nakamura T, Sone D, et al. Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis. Antimicrob Agents Chemother. 2013;57(4):1610–1616. doi:10.1128/AAC.02056-12 PMID:23318803
  • Baran R, Hay RJ, Tosti A, Haneke E. A new classification of onychomycosis. Br J Dermatol. 1998;139(4):567–571 PMID:9892897
  • Omi T, Numano K. The role of the CO2 laser and fractional CO2 laser in dermatology. Laser Ther. 2014;23(1):49–60. doi:10.5978/islsm.14-RE-01 PMID:24771971
  • Majid I, Imran S. Fractional CO2 laser resurfacing as monotherapy in the treatment of atrophic facial acne scars. J Cutan Aesthet Surg. 2014;7(2):87–92. doi:10.4103/0974-2077.138326 PMID:25136208
  • Baran R, Kaoukhov A. Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy. J Eur Acad Dermatol Venereol. 2005;19(1):21–29. doi:10.1111/j.1468-3083.2004.00988.x PMID:15649187

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.